Risk of recurrent ventricular tachyarrhythmia following the occurrence of a first ventricular arrhythmic event in patients with a primary prevention implantable cardioverter-defibrillator
Heart Rhythm · 2025
DOI: 10.1016/j.hrthm.2024.11.033 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Heart Rhythm, 2025. Verfasst von Matthew Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York. Hauptthemen laut MEDLINE: Death, Sudden, Cardiac, Defibrillators, Implantable, Heart Failure, Primary Prevention. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Gilead UK and Ireland Corporate Contributions.
Abstract (Originalsprache)
BACKGROUND: There are limited data on clinical and arrhythmic outcomes after a first ventricular tachyarrhythmia (VTA) in heart failure (HF) patients who receive a primary prevention implantable cardioverter-defibrillator (ICD). OBJECTIVE: This study was designed to quantify the burden of and to identify risk factors for recurrent VTA in this population and to evaluate the risk of all-cause mortality associated with recurrent VTA. METHODS: The study comprised 789 patients who experienced VTA following primary prevention ICD implantation in 5 ICD trials (MADIT-II, MADIT-RISK, MADIT-CRT, MADIT-RIT, RAID). Landmark analysis was used to quantify the burden and to identify predictors of recurrent VTA. Time-dependent analysis was used to evaluate the association of VTA recurrence with subsequent mortality. RESULTS: The mean age of the study patients was 63 years, and 17% were women. The cumulative probability of experiencing at least 1 recurrent VTA episode at 3 years after a first VTA episode was 60%; the recurrent VTA burden after a first event during 3 years was 2.8 episodes per patient. The risk of recurrent VTA remained ≥56% at 3 years regardless of baseline clinical and echocardiographic risk factors. VTA recurrence was associated with a significant 2-fold increased risk of subsequent all-cause mortality. CONCLUSION: Patients with a primary prevention ICD who experience an episode of VTA are at high risk of recurrent VTA, regardless of baseline risk factors. Recurrent VTA is associated with a pronounced increase in the risk of death. These findings suggest a need for early intervention after a first VTA in patients who receive a primary prevention ICD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York.
- Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York. Electronic address: mehmet_aktas@urmc.rochester.edu.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- Gilead UK and Ireland Corporate Contributions
- Boston Scientific Corporation
- University of Rochester Medical Center
- Gilead Sciences Inc
Zitieren
APA
Wang, M., Goldenberg, I., Younis, A., Goldenberg, I., Christof, M., Huang, D. T., McNitt, S., Polonsky, B., Kutyifa, V., Zareba, W., Ojo, A., & Aktaş, M. K. (2025). Risk of recurrent ventricular tachyarrhythmia following the occurrence of a first ventricular arrhythmic event in patients with a primary prevention implantable cardioverter-defibrillator. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2024.11.033
Vancouver
Wang M, Goldenberg I, Younis A, Goldenberg I, Christof M, Huang DT, et al. Risk of recurrent ventricular tachyarrhythmia following the occurrence of a first ventricular arrhythmic event in patients with a primary prevention implantable cardioverter-defibrillator. Heart Rhythm. 2025. doi:10.1016/j.hrthm.2024.11.033
BibTeX
@article{Wang2025,
author = {Wang, Matthew and Goldenberg, Ilan and Younis, Arwa and Goldenberg, Ido and Christof, Michael and Huang, David T and McNitt, Scott and Polonsky, Bronislava and Kutyifa, Valentina and Zareba, Wojciech and Ojo, Amole and Aktaş, Mehmet K},
title = {Risk of recurrent ventricular tachyarrhythmia following the occurrence of a first ventricular arrhythmic event in patients with a primary prevention implantable cardioverter-defibrillator},
journal = {Heart Rhythm},
year = {2025},
doi = {10.1016/j.hrthm.2024.11.033}
}
EUVIMED